Keywords
References
-
1.
World Drug Report 2014. 2014. Available from: https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
-
2.
Drugs in focus. 2011. Available from: http://www.emcdda.europa.eu/attachements.cfm/att_145850_EN_EMCDDA_DiF22_EN.pdf.
-
3.
Vorce SP, Knittel JL, Holler JM, Magluilo JJR, Levine B, Berran P, et al. A fatality involving AH-7921. J Anal Toxicol. 2014;38(4):226-30. [PubMed ID: 24523294]. https://doi.org/10.1093/jat/bku011.
-
4.
Loew G, Lawson J, Toll L, Frenking G, Berzetei-Gurske I, Polgar W. Structure activity studies of two classes of beta-amino-amides: the search for kappa-selective opioids.In: Harris LS, editor. Problems of drug dependence 1988. NIDA Research Monograph 90: Proceedings of the 50th Annual Scientific Meeting. 1988; Rockville, Maryland. US Department of Health and Human Services; p. 144-51.
-
5.
Harper NJ, Veitch GB, Wibberley DG. 1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics. J Med Chem. 1974;17(11):1188-93. [PubMed ID: 4416926].
-
6.
Hayes AG, Tyers MB. Determination of receptors that mediate opiate side effects in the mouse. Br J Pharmacol. 1983;79(3):731-6. [PubMed ID: 6317119].
-
7.
Brittain RT, Kellett DN, Neat ML, Stables R. Proceedings: Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides. Br J Pharmacol. 1973;49(1):158-9. [PubMed ID: 4207044].